Repare Therapeutics Inc. Insider Trading for June 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Repare Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Repare Therapeutics Inc. for June 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Option Exercise | C | 0.00 | 458,282 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Option Exercise | C | 0.00 | 875,568 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,350 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,708 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Option Exercise | C | 0.00 | 8,475 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Option Exercise | C | 0.00 | 111,361 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,443,883 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Option Exercise | C | 0.00 | 61,791 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Option Exercise | C | 0.00 | 68,398 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Option Exercise | C | 0.00 | 156,335 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,054,198 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | P | 20.00 | 100,000 | 2,000,000 | 3,419,451 | 3.3 M to 3.4 M (+3.01 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | P | 20.00 | 150,000 | 3,000,000 | 608,282 | 458.3 K to 608.3 K (+32.73 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | C | 0.00 | 458,282 | 0 | 458,282 | 0 to 458.3 K |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | C | 0.00 | 875,568 | 0 | 3,319,451 | 2.4 M to 3.3 M (+35.83 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | C | 0.00 | 3,350 | 0 | 84,737 | 81.4 K to 84.7 K (+4.12 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | C | 0.00 | 3,708 | 0 | 93,798 | 90.1 K to 93.8 K (+4.12 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | C | 0.00 | 8,475 | 0 | 214,390 | 205.9 K to 214.4 K (+4.12 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | C | 0.00 | 111,361 | 0 | 2,817,021 | 2.7 M to 2.8 M (+4.12 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | C | 0.00 | 2,443,883 | 0 | 2,443,883 | 0 to 2.4 M |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | C | 0.00 | 61,791 | 0 | 81,387 | 19.6 K to 81.4 K (+315.32 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | C | 0.00 | 68,398 | 0 | 90,090 | 21.7 K to 90.1 K (+315.31 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | C | 0.00 | 156,335 | 0 | 205,915 | 49.6 K to 205.9 K (+315.32 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | C | 0.00 | 2,054,198 | 0 | 2,705,660 | 651.5 K to 2.7 M (+315.32 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Option Exercise | C | 0.00 | 458,282 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Option Exercise | C | 0.00 | 875,568 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Option Exercise | C | 0.00 | 3,350 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Option Exercise | C | 0.00 | 3,708 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Option Exercise | C | 0.00 | 8,475 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Option Exercise | C | 0.00 | 111,361 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Option Exercise | C | 0.00 | 2,443,883 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Option Exercise | C | 0.00 | 61,791 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Option Exercise | C | 0.00 | 68,398 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Option Exercise | C | 0.00 | 156,335 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Option Exercise | C | 0.00 | 2,054,198 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | P | 20.00 | 100,000 | 2,000,000 | 3,419,451 | 3.3 M to 3.4 M (+3.01 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | P | 20.00 | 150,000 | 3,000,000 | 608,282 | 458.3 K to 608.3 K (+32.73 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | C | 0.00 | 458,282 | 0 | 458,282 | 0 to 458.3 K |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | C | 0.00 | 875,568 | 0 | 3,319,451 | 2.4 M to 3.3 M (+35.83 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | C | 0.00 | 3,350 | 0 | 84,737 | 81.4 K to 84.7 K (+4.12 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | C | 0.00 | 3,708 | 0 | 93,798 | 90.1 K to 93.8 K (+4.12 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | C | 0.00 | 8,475 | 0 | 214,390 | 205.9 K to 214.4 K (+4.12 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | C | 0.00 | 111,361 | 0 | 2,817,021 | 2.7 M to 2.8 M (+4.12 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | C | 0.00 | 2,443,883 | 0 | 2,443,883 | 0 to 2.4 M |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | C | 0.00 | 61,791 | 0 | 81,387 | 19.6 K to 81.4 K (+315.32 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | C | 0.00 | 68,398 | 0 | 90,090 | 21.7 K to 90.1 K (+315.31 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | C | 0.00 | 156,335 | 0 | 205,915 | 49.6 K to 205.9 K (+315.32 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | C | 0.00 | 2,054,198 | 0 | 2,705,660 | 651.5 K to 2.7 M (+315.32 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Option Exercise | C | 0.00 | 458,282 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Option Exercise | C | 0.00 | 875,568 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Option Exercise | C | 0.00 | 3,350 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Option Exercise | C | 0.00 | 3,708 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Option Exercise | C | 0.00 | 8,475 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Option Exercise | C | 0.00 | 111,361 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Option Exercise | C | 0.00 | 2,443,883 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Option Exercise | C | 0.00 | 61,791 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Option Exercise | C | 0.00 | 68,398 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Option Exercise | C | 0.00 | 156,335 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Option Exercise | C | 0.00 | 2,054,198 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | P | 20.00 | 100,000 | 2,000,000 | 3,419,451 | 3.3 M to 3.4 M (+3.01 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | P | 20.00 | 150,000 | 3,000,000 | 608,282 | 458.3 K to 608.3 K (+32.73 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | C | 0.00 | 458,282 | 0 | 458,282 | 0 to 458.3 K |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | C | 0.00 | 875,568 | 0 | 3,319,451 | 2.4 M to 3.3 M (+35.83 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | C | 0.00 | 3,350 | 0 | 84,737 | 81.4 K to 84.7 K (+4.12 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | C | 0.00 | 3,708 | 0 | 93,798 | 90.1 K to 93.8 K (+4.12 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | C | 0.00 | 8,475 | 0 | 214,390 | 205.9 K to 214.4 K (+4.12 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | C | 0.00 | 111,361 | 0 | 2,817,021 | 2.7 M to 2.8 M (+4.12 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | C | 0.00 | 2,443,883 | 0 | 2,443,883 | 0 to 2.4 M |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | C | 0.00 | 61,791 | 0 | 81,387 | 19.6 K to 81.4 K (+315.32 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | C | 0.00 | 68,398 | 0 | 90,090 | 21.7 K to 90.1 K (+315.31 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | C | 0.00 | 156,335 | 0 | 205,915 | 49.6 K to 205.9 K (+315.32 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | C | 0.00 | 2,054,198 | 0 | 2,705,660 | 651.5 K to 2.7 M (+315.32 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Segal Lloyd Mitchell | President and CEO | Buy | P | 20.00 | 5,000 | 100,000 | 5,000 | 0 to 5 K |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Forte Steve | EVP, Chief Financia ... | Buy | P | 20.00 | 5,000 | 100,000 | 5,000 | 0 to 5 K |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | SCHAFER CAROL | Director | Buy | P | 20.00 | 8,000 | 160,000 | 8,000 | 0 to 8 K |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Morrison Briggs | Director | Buy | P | 20.00 | 4,800 | 96,000 | 4,800 | 0 to 4.8 K |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | RHOADS ANN D | Director | Buy | P | 20.00 | 4,000 | 80,000 | 4,000 | 0 to 4 K |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Bonita David P | Director | Option Exercise | C | 0.00 | 2,601,325 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Bonita David P | Director | Buy | P | 20.00 | 99,200 | 1,984,000 | 99,200 | 0 to 99.2 K |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Bonita David P | Director | Buy | P | 20.00 | 675,000 | 13,500,000 | 3,276,325 | 2.6 M to 3.3 M (+25.95 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Bonita David P | Director | Buy | C | 0.00 | 2,601,325 | 0 | 2,601,325 | 0 to 2.6 M |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,601,325 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | ORBIMED ADVISORS LLC | Director | Buy | P | 20.00 | 99,200 | 1,984,000 | 99,200 | 0 to 99.2 K |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | ORBIMED ADVISORS LLC | Director | Buy | P | 20.00 | 675,000 | 13,500,000 | 3,276,325 | 2.6 M to 3.3 M (+25.95 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 2,601,325 | 0 | 2,601,325 | 0 to 2.6 M |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Redmile Group, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,586,174 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Redmile Group, LLC | 10% Owner | Buy | C | 0.00 | 1,586,174 | 0 | 1,586,174 | 0 to 1.6 M |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Option Exercise | C | 0.00 | 1,288,948 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Option Exercise | C | 0.00 | 3,603,161 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Buy | P | 20.00 | 500,000 | 10,000,000 | 5,392,109 | 4.9 M to 5.4 M (+10.22 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Buy | C | 0.00 | 1,288,948 | 0 | 4,892,109 | 3.6 M to 4.9 M (+35.77 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Buy | C | 0.00 | 3,603,161 | 0 | 3,603,161 | 0 to 3.6 M |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Option Exercise | C | 0.00 | 952,191 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Option Exercise | C | 0.00 | 1,801,581 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Buy | P | 20.00 | 250,000 | 5,000,000 | 3,003,772 | 2.8 M to 3 M (+9.08 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Buy | C | 0.00 | 952,191 | 0 | 2,753,772 | 1.8 M to 2.8 M (+52.85 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Buy | C | 0.00 | 1,801,581 | 0 | 1,801,581 | 0 to 1.8 M |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | MPM BioVentures 2014, L.P. | 10% Owner | Option Exercise | C | 0.00 | 952,191 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | MPM BioVentures 2014, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,801,581 | 0 | 0 | |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | MPM BioVentures 2014, L.P. | 10% Owner | Buy | P | 20.00 | 250,000 | 5,000,000 | 3,003,772 | 2.8 M to 3 M (+9.08 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | MPM BioVentures 2014, L.P. | 10% Owner | Buy | C | 0.00 | 952,191 | 0 | 2,753,772 | 1.8 M to 2.8 M (+52.85 %) |
| Jun 25 2020 | RPTX | Repare Therapeutic ... | MPM BioVentures 2014, L.P. | 10% Owner | Buy | C | 0.00 | 1,801,581 | 0 | 1,801,581 | 0 to 1.8 M |
| Jun 19 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Option Exercise | A | 20.00 | 41,240 | 824,800 | 41,240 | |
| Jun 19 2020 | RPTX | Repare Therapeutic ... | Segal Lloyd Mitchell | President and CEO | Option Exercise | A | 20.00 | 354,668 | 7,093,360 | 354,668 | |
| Jun 19 2020 | RPTX | Repare Therapeutic ... | RHOADS ANN D | Director | Option Exercise | A | 20.00 | 38,907 | 778,140 | 38,907 | |
| Jun 19 2020 | RPTX | Repare Therapeutic ... | Koehler Maria | EVP, Chief Medical ... | Option Exercise | A | 20.00 | 41,240 | 824,800 | 41,240 | |
| Jun 19 2020 | RPTX | Repare Therapeutic ... | Forte Steve | EVP, Chief Financia ... | Option Exercise | A | 20.00 | 41,240 | 824,800 | 41,240 |